Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details) - Schedule of stock option activities

v3.21.2
Shareholders' Deficit (Details) - Schedule of stock option activities - Stock options [Member]
 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]  
Number of Options, Balance Outstanding, Beginning | shares 8,445,698
Weighted Average Exercise Price, Balance Outstanding, Beginning | $ / shares $ 0.4
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 5 years 1 month 6 days
Aggregate Intrinsic Value, Balance Outstanding, Beginning | $ $ 48,000
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term (Years), Granted | shares
Aggregate Intrinsic Value, Granted | $
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Remaining Contractual Term (Years), Forfeited | shares
Aggregate Intrinsic Value, Forfeited | $
Number of Options, Balance Outstanding, Ending | $ $ 8,445,698
Weighted Average Exercise Price, Balance Outstanding, Ending | $ / shares $ 0.4
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 4 years 3 months 29 days
Aggregate Intrinsic Value, Balance Outstanding, Ending | $ $ 2,160
Number of Options, Exercisable | shares 8,445,698
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.4
Weighted Average Remaining Contractual Term (Years), Exercisable, 4 years 3 months 29 days
Aggregate Intrinsic Value, Exercisable | $ $ 2,160